Welcome to LookChem.com Sign In|Join Free

CAS

  • or

681809-03-0

C37H46N4O8 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

681809-03-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 681809-03-0 Structure

  • Basic information

    1. Product Name: C37H46N4O8
    2. Synonyms: C37H46N4O8
    3. CAS NO:681809-03-0
    4. Molecular Formula:
    5. Molecular Weight: 674.794
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 681809-03-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C37H46N4O8(CAS DataBase Reference)
    10. NIST Chemistry Reference: C37H46N4O8(681809-03-0)
    11. EPA Substance Registry System: C37H46N4O8(681809-03-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 681809-03-0(Hazardous Substances Data)

681809-03-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 681809-03-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,1,8,0 and 9 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 681809-03:
(8*6)+(7*8)+(6*1)+(5*8)+(4*0)+(3*9)+(2*0)+(1*3)=180
180 % 10 = 0
So 681809-03-0 is a valid CAS Registry Number.

681809-03-0Downstream Products

681809-03-0Relevant articles and documents

Substituted cycloalkyl P1' hepatitis C virus inhibitors

-

Page/Page column 96-98, (2010/02/06)

The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 681809-03-0